References
- Schultes RE. INDOLE ALKALOIDS IN PLANT HALLUCINOGENS 1. Planta Med. 1976;29(04):330–342. doi:10.1055/s-0028-1097672
- Schultes RE. Hallucinogenic plants: their earliest botanical descriptions. J Psychedelic Drugs. 1979;11:13–24.
- Hofmann A, Heim R, Brack A, Kobel H. Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe mexicana Heim [Psilocybin, a psychotropic substance from the Mexican mushroom Psilicybe mexicana Heim]. Experientia. 1958;14:107–109.
- Hofmann A, Frey A, Ott H, Petr Zilka T, Troxler F. Konstitutionsaufklärung und synthese von psilocybin [elucidation of the structure and the synthesis of psilocybin]. Experientia. 1958;14:397–399.
- DEA. Drug Scheduling. Available from: https://www.dea.gov/drug-information/drug-scheduling. Accessed June 1, 2023.
- Research and Markets. Psychedelic drugs market, global forecast. Available from: https://www.researchandmarkets.com/reports/5240207/psychedelic-drugs-market-by-drugs-lsd?utm_source=GNOM&utm_medium=PressRelease&utm_code=894w6r&utm_campaign=1513085+-+Global+Psychedelic+Drugs+Market+Report+2020%3a+Market+Size+is+Projected+to+Reach+%2410.75+Billion+by+2027&utm_exec=chdo54prd. Accessed June 1, 2023.
- ClinicalTrials.gov. Available from: https://clinicaltrials.gov/. Accessed December 12, 2023.
- FDA. Development and approval process. Available from: https://www.fda.gov/drugs/development-approval-process-drugs. Accessed June 1, 2023.
- FDA. Breakthrough therapy. Available from: https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/breakthrough-therapy. Accessed June 1, 2023.
- Compass Pathways. COMPASS pathways receives FDA breakthrough therapy designation. Available from: https://compasspathways.com/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression/. Accessed June 1, 2023.
- Business Wire. FDA grants breakthrough therapy designation. Available from: https://www.businesswire.com/news/home/20191122005452/en/FDA-grants-Breakthrough-Therapy-Designation-to-Usona-Institutes-psilocybin-program-for-major-depressive-disorder. Accessed June 1, 2023.
- Pharma News Intelligence. Understanding US food and drug administration (FDA) approval processes. https://pharmanewsintel.com/features/understanding-us-food-and-drug-administration-fda-approval-processes. Accessed June 1, 2023.
- Lowe H, Toyang N, Steele B, et al. The therapeutic potential of psilocybin. Molecules. 2021;26(10):2948. doi:10.3390/molecules26102948
- Biotechnology Innovation Organization. Clinical development success rates and contributing factors 2011–2020. https://go.bio.org/rs/490-EHZ-999/images/ClinicalDevelopmentSuccessRates2011_2020.pdf. Accessed June 1, 2023.
- FDA. Step 3 clinical research. Available from: https://www.fda.gov/patients/drug-development-process/step-3-clinical-research#:~:text=Study%20Participants%3A%2020%20to%20100,people%20with%20the%20disease%2Fcondition.&text=During%20Phase%201%20studies%2C%20researchers,condition%20participate%20in%20Phase%201. Accessed June 1, 2023.
- FDA. Fast Track. Available from: https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/fast-track. Accessed June 1, 2023.
- FDA. Psychedelic drugs: considerations for clinical investigations. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations. Accessed December 12, 2023.
- Schulz KF. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408–412. doi:10.1001/jama.1995.03520290060030
- NAMI. Mental health by the numbers. Available from: https://www.nami.org/mhstats. Accessed June 1, 2023.
- Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters [published correction appears in biostatistics. Biostatistics. 2019;20(2):273–286.
- NIH. CinicalTrials.gov glossary terms. Available from: https://clinicaltrials.gov/ct2/about-studies/glossary. Accessed June 1, 2023.
- Definitive Healthcare. How to recruit patients for clinical trials in 3 steps. Available from: https://www.definitivehc.com/blog/recruit-patients-for-clinical-trials#:~:text=Finding%20people%20willing%20to%20participate,in%20the%20clinical%20trial%20market. Accessed June 1, 2023.